Showing results (161-170 of 242) with videos related to
Sort By:
Pageof 25
Molecular Cancer Therapeutics|August 12, 2018
iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic CancerJustin H Lo, Liangliang Hao, Mandar D Muzumdar, et al.Cell|August 3, 2010
A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 responseMaite Huarte, Mitchell Guttman, David Feldser, et al.Immunity|September 6, 2015
Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell ResponsesNikhil S Joshi, Elliot H Akama-Garren, Yisi Lu, et al.Genes & Development|July 19, 2011
Nuclear factor I/B is an oncogene in small cell lung cancerAlison L Dooley, Monte M Winslow, Derek Y Chiang, et al.Cancer Research|May 19, 2007
Dominant-negative but not gain-of-function effects of a p53.R270H mutation in mouse epithelium tissue after DNA damageSusan W P Wijnhoven, Ewoud N Speksnijder, Xiaoling Liu, et al.Nature|June 10, 2005
MicroRNA expression profiles classify human cancersJun Lu, Gad Getz, Eric A Miska, et al.Cell|February 5, 2019
Commensal Microbiota Promote Lung Cancer Development via γδ T CellsChengcheng Jin, Georgia K Lagoudas, Chen Zhao, et al.Cell|June 24, 2014
KRAS and YAP1 converge to regulate EMT and tumor survivalDiane D Shao, Wen Xue, Elsa B Krall, et al.Proceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Small RNA combination therapy for lung cancerWen Xue, James E Dahlman, Tuomas Tammela, et al.Proceedings of the National Academy of Sciences of the United States of America|June 28, 2017
Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survivalVasilena Gocheva, Alexandra Naba, Arjun Bhutkar, et al.Pageof 25